Dr. Robby Emile Atala, MD

Dr. Atala practices at Baylor Scott & White Medical Center - Grapevine in Grapevine, Texas, part of Baylor Scott & White Health.

Dr. Atala's NPI, 1942430665, was assigned on July 15, 2009. Dr. Atala graduated from Lebanese University School of Medicine in 2004. Dr. Atala holds Texas license P6132.

Dr. Atala's primary practice is Baylor Scott & White Medical Center - Grapevine, at 1650 W College St, Grapevine, TX 76051 in Tarrant County. The practice phone is (817) 481-1588.

Dr. Atala's primary practice is Baylor Scott & White Medical Center - Grapevine in Grapevine, Texas, part of Baylor Scott & White Health. Dr. Atala is also affiliated with Texas Health Fort Worth. The medical group on file is HealthTexas Provider Network (HTPN). Dmand AI also links Dr. Atala to 1 more hospital, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Atala practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Atala's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Atala is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Atala's licenses on file in 4 states: Texas, Louisiana, New Mexico and New Jersey.

Dmand AI lists acute respiratory failure, anemia, cardiac arrhythmia, cellulitis, chest pain, congestive heart failure, dementia and electrolyte disorders among the conditions Dr. Atala treats.

CMS data shows 790 Medicare services from Dr. Atala across 5 procedure codes in 2024, for 304 Medicare patients. Medicare paid $63,063 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 304 Medicare patients who saw Dr. Atala in 2024. The largest group is 75 to 84, with 126 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Atala's median patient age at 74, with 49% women.

In 2024, Dr. Atala wrote 478 Medicare Part D claims for 194 patients. 89% of them were for generic drugs. CMS names the drug for 191 of them, across 10 drugs with 11 or more claims each, at $20,115 in total drug cost. In 2023, CMS named 149 claims across 9 drugs.

Dr. Atala accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Atala in 2020. 2020 was the busiest year, with 2. Dr. Atala's most frequent co-authors are Snehal Rudresh Bhatt, MD, Mohamad Hadi Khafaja, MD and Philip J. Kroth, MD.

CMS Open Payments shows 12 general payments to Dr. Atala from 6 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $118.

Dr. Atala graduated from Lebanese University School of Medicine in 2004. Dr. Atala is a member of ACP and SHM.

Dr. Atala is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.